• Home
  • » 
  • Reports
  • » 
  • Women’s Digital Health Market by Type ...

Women's Health

Women’s Digital Health Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    April 2022

  • Pages
    294

  • View Count
    3586

  • Buy Now

Example Insights

Women-Digital-Health-Market1-Context-thumb Women-Digital-Health-Market1-List-of-Solutions-thumb Women-Digital-Health-Market1-Distribution-by-Type-of-Solution-thumb Women-Digital-Health-Market1-Regional-Landscape-thumb
Women-Digital-Health-Market1-Partnerships-and-Collaborations-thumb Women-Digital-Health-Market1-Funding-and-Investments-thumb Women-Digital-Health-Market1-Start-Up-Health-Indexing-thumb Women-Digital-Health-Market1-Global-Event-Analysis-thumb
Women-Digital-Health-Market1-Development-Roadmap-thumb Women-Digital-Health-Market1-Annualized-Rate-thumb    

Report Description

Over the past few years, there have been several advancements in the field of digital health market; this has led to an increase in the adoption of digital healthcare solutions. Specifically, the outbreak of COVID-19 pandemic prompted people all over the world to rely on digital medium to receive healthcare remotely. Females constitute 49.6% of the world’s total population and, in one of its reports, the US department of labor reported that females use digital health care solutions more than men. Further, in a recent survey, it was founded that the percentage of women adopting tele health platform rose from 13% to 38% post the outbreak of COVID-19. Currently, there are more than 100 marketed solutions focused on women’s digital health; these include applications, software and devices. Some of these solutions have also been approved by the USFDA for therapeutic applications in areas, such as reproductive health and menstrual health. It is worth noting that, NC° Birth Control, developed by Natural Cycles, was the first application to receive approval from US FDA in 2018; the application can be used as a method of contraception and helps in regularly tracking menstrual cycle. 

Several developers are actively engaged in the development of solutions related to women’s digital health. In fact, a number of start-ups focused on women’s digital health have been established in the last few years, indicating the growing interest in this sector. A variety of solutions, such as women’s health diagnostic devices, women’s health applications as well as digital services for women, primarily targeting reproductive health, menstrual health, pelvic floor care and fetal health, are being developed by digital women’s health solution providers. Owing to the fact that women’s digital health is a relatively niche field, extensive research and development is required in order to meet the existing unmet needs of women. Having said that, the domain has attracted significant attention from the investors and healthcare venture capitalists, which have invested close to USD 3 billion over the past few years, enabling the femtech business flourish.  Given the increasing research efforts and active involvement of investors, we expect a variety of applications and devices focused on improving women’s health to be developed, enabling the women’s digital health market to witness steady growth over the coming years.

Scope of the Report

The “Women’s Digital Health Market by Type of Solutions (Applications / Software, Devices and Services), Therapeutic Application Areas (Fetal Health, General Wellness, Menstrual Cycle, Pelvic Care, Reproductive Health / Fertility, and Other Therapeutic Areas), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely future potential of women’s digital health solution providers, over the next decade. The study underlines an in-depth analysis, highlighting the diverse capabilities of various industry stakeholders engaged in this field. In addition to other elements, the report includes:

  • A detailed assessment of the overall market landscape of women’s digital health solution providers along with the information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services). In addition to this, the chapter provides details on the type of solution(s) offered along with information on their current status of development, ratings, therapeutic application area, usage period with respect to pregnancy, purpose and end-users. 
  • Detailed profiles of key players engaged in the women’s digital health market (shortlisted on the basis of company size). Each profile features a brief overview of the company, its financial information (if available), details on the solution(s) offered, recent developments and an informed future outlook.A detailed analysis of the various funding and investments made since 2016, including venture capital financing, secondary offering, private placement, grant, debt financing and other equity in the companies focused on offering solutions for women’s digital health.
  • An analysis of the partnerships that have been established in this domain since 2015, covering commercialization agreements, distribution agreements, licensing and distribution agreements, product / technology integration agreements, product development agreements, service agreements, manufacturing agreements, R&D agreements, and product development and commercialization agreements.
  • An analysis of the start-ups / small players (established in the last ten years, with less than 50 employees) engaged in the women’s digital health market, featuring spider web representations based on several relevant parameters, such as number of solution(s) offered, therapeutic application areas, usage period with respect to pregnancy, details on funding (including funding amount, and evolution of investment activity) and partnership activity.
  • A detailed analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated department of participant, active speakers (in terms of number of events). Additionally, the chapter highlights geographical mapping of the upcoming events.
  • A roadmap for the development of women’s digital health solutions, such as applications and devices considering various factors that impact pre-development, development and post-development process. It also highlights the current unmet needs in digital health solutions for women across different therapeutic application areas.

One of the key objectives of the report was to understand the primary growth drivers and estimate the potential opportunities for the women’s digital health market. We have provided an informed estimate of the evolution of women’s digital health market for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented across type of solution(s) (applications / software, devices and services offered / available), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic area, reproductive health / fertility and others) and key geographies (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the report were influenced by discussions held with several stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order):

  • Maryam Ziaei (Founder and Chief Executive Officer, iSONO Health)
  • Honny Hillegonda Kipnis Groen (Chief Marketing Officer, Illumigyn)
  • Sven Mulfinger (Co-Founder & Chief Operating Officer, A Thousand Collibris)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Who are the leading industry players offering solutions for women’s digital health?
  • Which women’s digital health applications and devices have been approved by the FDA?
  • What kind of partnership models are commonly adopted by industry and non-industry stakeholders?
  • Who are the key investors active in the field of women’s digital health?
  • What is the focus of global events / conferences held for women’s digital health?
  • What is the roadmap for the development of women’s digital health solutions?
  • What are the various unmet needs across different therapeutic application areas in the current women’s digital health market?
  • How is the current and future opportunity related to women’s digital health likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 provides an executive summary of the key insights captured during our research. It offers a high-level view on the current status of women’s digital health market and its likely evolution in the short to mid-term and long term.

Chapter 3 provides a general introduction to the women’s digital health sector, along with information on wearable devices, mobile applications and services for monitoring / diagnosis, providing details related to the current and future trends affiliated to the domain. Further, it includes a brief discussion on importance of femtech industries in women’s healthcare. The chapter also highlights key concepts involved in the development of women’ digital health, featuring discussion on challenges faced during the development of women’s digital healthcare.

Chapter 4 provides an overall market landscape of women’s digital health solution providers along with the information on their year of establishment, company size, location of headquarters, type of solution(s) offered (applications / software, devices and services). In addition to this, the chapter provides details on the type of solution(s) offered along with information on their current status of development, ratings, therapeutic application area, usage period with respect to pregnancy, purpose and end-users.
 
Chapter 5 includes detailed profiles of the key players based in North America that are engaged in the women’s digital health market. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.
 
Chapter 6 includes detailed profiles of the key players based in Europe, Asia-Pacific, and Middle East and North Africa that are engaged in the women’s digital health market. Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.

Chapter 7 presents detailed analysis of the various funding and investments made since 2016, including venture capital financing, secondary offering, private placement, grant, debt financing and other equity in the companies focused on offering solutions for women’s digital health. 

Chapter 8 features an insightful analysis of the partnerships that have been established in this domain since 2015, covering commercialization agreements, distribution agreements, licensing and distribution agreements, product / technology integration agreements, product development agreements, service agreements, manufacturing agreements, R&D agreements, and product development and commercialization agreements.

Chapter 9 includes an analysis of the start-ups / small players (established in the last ten years, with less than 50 employees) engaged in the women’s digital health market, featuring heat map representation based on several relevant parameters, such as number of solution(s) offered, therapeutic application areas, usage period with respect to pregnancy, details on funding (including funding amount, and evolution of investment activity) and partnership activity.     

Chapter 10 includes the global events attended by the participants, based on several relevant parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated department of participant, active speakers (in terms of number of events). Additionally, the chapter highlights geographical mapping of the upcoming events.

Chapter 11 provides information on the affiliated trends, key drivers and challenges associated with women’s digital health solutions, under a reliable SWOT framework. Further, the chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall women’s digital health market.

Chapter 12 features roadmap for the development of women’s digital health solutions, such as applications and devices considering various factors that impact pre-development, development and post-development process. It also highlights the current unmet needs in digital health solutions for women across different therapeutic application areas.

Chapter 13 features an insightful market forecast analysis, highlighting the likely growth of the women’s digital health solution market for the time period 2022-2035. In order to provide details on the future outlook, our year-wise projections of the current and future opportunity have further been segmented across type of solution(s) (applications / software, devices and services offered / available), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic area, reproductive health / fertility and others) and key geographies (North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa). 

Chapter 14 provides a general overview on the role of digitalization in women’s life and the impact of COVID-19 on the adoption of digital health solutions among women. The chapter also includes a discussion on the usage of digital solutions by women for learning new skills, and stepping forward in personal and professional life, the existing gender gap and impact of AI in order to resolve the challenges associated with gender gap.

Chapter 15 provides a general overview on adoption of digital medium in healthcare sector, including information on artificial intelligence, machine learning, deep learning and metaverse, covering details related to the current and future trends affiliated to the domain. Further, it includes companies engaged in using artificial intelligence and machine learning in healthcare solutions. In addition to this, the chapter includes discussion on how digital mediums will reshape the future of the medical industry.

Chapter 16 summarizes the entire report, highlighting various facts related to contemporary market trends and the likely evolution of the women’s digital health market. 

Chapter 17 is a collection of interview transcripts of discussions held with various key stakeholders in this market. In this chapter, we have presented detailed transcripts of interviews held with (in alphabetical order) Maryam Ziaei (Founder and Chief Executive Officer, iSONO Health), Honny Hillegonda Kipnis Groen (Chief Marketing Officer, Illumigyn) and Sven Mulfinger (Co-Founder & Chief Operating Officer, A Thousand Collibris).

Chapter 18 is an appendix that contains tabulated data and numbers for all the figures in the report.

Chapter 19 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Digital Health
3.3. Women’s Digital Health
3.4. Importance of Women’s Digital Health
3.5. Challenges Related to Women’s Digital Health
3.6. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2 Women’s Digital Health: Product Pipeline
4.2.1 Analysis by Type of Solution
4.2.2 Analysis by Current Status of Development
4.2.3 Analysis of Women’s Digital Health Applications by Ratings
4.2.4 Analysis by Therapeutic Application Area
4.2.5 Analysis by Usage Period with respect to Pregnancy
4.2.6 Analysis by Purpose
4.2.7 Analysis by End-Users
4.2.8 Analysis by Therapeutic Application Area and Type of Solution

4.3 Women’s Digital Health: Developer Landscape
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3 Analysis by Region of Headquarters
4.3.4 Analysis by Company Size and Region of Headquarters
4.3.5 Analysis by Location of Headquarters
4.3.6 Leading Players: Analysis by Number of Solutions
4.3.7 Regional Landscape: Analysis by Type of Solution

5. WOMEN’S DIGITAL HEALTH DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES
5.1. Chapter Overview
5.2. Garmin 
5.2.1. Company Overview
5.2.2. Product / Service Portfolio
5.2.3. Women’s Digital Health Product / Service(s) Offered
5.2.4. Recent Developments and Future Outlook

5.3. Kindbody 
5.3.1. Company Overview
5.3.2. Product / Service Portfolio
5.3.3. Women’s Digital Health Product / Service(s) Offered
5.3.4. Recent Developments and Future Outlook

5.4. LetsGetChecked
5.4.1. Company Overview
5.4.2. Product / Service Portfolio
5.4.3. Women’s Digital Health Product / Service(s) Offered
5.4.4. Recent Developments and Future Outlook

5.5. Maven Clinic
5.5.1. Company Overview
5.5.2. Product / Service Portfolio
5.5.3. Women’s Digital Health Product / Service(s) Offered
5.5.4. Recent Developments and Future Outlook

5.6. Ro 
5.6.1. Company Overview
5.6.2. Product / Service Portfolio
5.6.3. Women’s Digital Health Product / Service(s) Offered
5.6.4. Recent Developments and Future Outlook

5.7. Willow Innovations
5.7.1. Company Overview
5.7.2. Product / Service Portfolio
5.7.3. Women’s Digital Health Product / Service(s) Offered
5.7.4. Recent Developments and Future Outlook

6. WOMEN’S DIGITAL HEALTH DEVELOPERS IN EUROPE, ASIA-PACIFIC AND MIDDLE EAST & NORTH AFRICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Flo Health
6.2.1. Company Overview
6.2.2. Product / Service Portfolio
6.2.3. Women’s Digital Health Product / Service(s) Offered
6.2.4. Recent Developments and Future Outlook

6.3. Hubble Connected
6.3.1. Company Overview
6.3.2. Product / Service Portfolio
6.3.3. Women’s Digital Health Product / Service(s) Offered
6.3.4. Recent Developments and Future Outlook

6.4. International Medical Center
6.4.1. Company Overview
6.4.2. Product / Service Portfolio
6.4.3. Women’s Digital Health Product / Service(s) Offered
6.4.4. Recent Developments and Future Outlook

7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding
7.3. Women’s Digital Health: Funding and Investment Analysis
7.3.1. Analysis by Year, Type of Funding and Amount Invested
7.3.2. Analysis by Year of Investment
7.3.3. Analysis by Amount Invested
7.3.4. Analysis by Type of Funding
7.3.5. Analysis by Type of Funding and Amount Invested
7.3.6. Most Active Players: Analysis by Number of Funding Instances
7.3.7. Most Active Players: Analysis by Amount Raised
7.3.8. Key Investors: Analysis by Number of Instances
7.3.9. Analysis by Type of Solution
7.3.10. Analysis by Type of Solution and Amount Invested
7.3.11. Analysis by Therapeutic Application Area
7.3.12. Analysis by Geography
7.3.13. Analysis by Year, Therapeutic Application Area and Amount Invested
7.3.14. Summary of Investments

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2 Partnership Models
8.3. List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Product / Solution
8.3.4. Analysis by Type of Partner
8.3.5. Analysis by Year of Partnership and Type of Partner
8.3.6. Analysis by Type of Partnership and Product / Solution
8.3.7. Most Active Players: Analysis by Number of Partnerships
8.3.8. Leading Players: Analysis by Type of Partnership
8.3.9. Regional Analysis
8.3.10. Intercontinental and Intracontinental Agreements

9. START UP HEALTH INDEXING
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Benchmarking of Start-ups
9.3.1. Analysis by Type of Product / Solution
9.3.2. Analysis by Therapeutic Application Area
9.3.3. Analysis by Usage Period with respect to Pregnancy
9.3.4 Analysis by Partnership Activity
9.3.5. Analysis by Funding Activity
9.3.6. Analysis by Progression of Funding
9.3.7. Analysis by Type of Funding
9.3.8. Analysis by Location of Headquarters
9.3.9. Start-up Health Indexing: Roots Analysis Perspective

10. GLOBAL EVENTS ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Events related to Women’s Digital Health
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Geography
10.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
10.3.6. Most Active Event Organizers: Analysis by Number of Events
10.3.7. Most Active Participants: Analysis by Number of Events
10.3.8. Analysis by Seniority Level of Participants
10.3.9. Most Active Speakers: Analysis by Number of Events
10.3.10. Geographical Mapping of Upcoming Events

11. SWOT ANALYSIS
11.1. Chapter Overview
11.2. Women’s Digital Health: SWOT Analysis
11.2.1. Comparison of SWOT Factors
11.2.1.1. Strengths 
11.2.1.2. Weaknesses
11.2.1.3. Opportunities
11.2.1.4. Threats 

12. PRODUCT DEVELOPMENT AND SUCCESS ANALYSIS
12.1. Chapter Overview
12.2. Methodology
12.3. Product Development and Success Analysis of Women’s Digital Health Applications
12.3.1. Competitiveness Analysis of Top Applications
12.3.2. Top Five Applications Focused on Women’s Digital Health
12.3.2.1. Flo
12.3.2.2. Clue Period Tracker
12.3.2.3. Ovulation & Period Tracker
12.3.2.4. NC° Birth Control
12.3.2.5. Maya
12.3.3. Average Score Required for the Success of Applications
12.4. Product Development and Success Analysis of Women’s Digital Health Devices
12.4.1. Competitiveness Analysis of Top Devices
12.4.2. Top 5 Devices Focused on Women’s Digital Health
12.4.2.1. Elvie Trainer
12.4.2.2. Ivy
12.4.2.3. breathe ilo
12.4.2.4. Roo
12.4.2.5. Embr Wave 2: Thermal Wellness
12.4.3. Average Score Required for the Success of Devices
12.5. Women’s Digital Health: Unmet Needs
12.5.1. Analysis by Therapeutic Application Areas and Type of Solutions
12.5.2. Analysis by Type of Solutions and Usage Period of Solution with respect to Pregnancy
12.5.3. Women’s Digital Health Solutions: Estimated Average Number of Users Across Various Therapeutic Application Areas

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Women’s Digital Health Market, 2022-2035
13.3.1. Women’s Digital Health Market, 2022-2035: Distribution by Type of Solution
13.3.1.1. Women’s Digital Health Market for Applications / Software, 2022-2035
13.3.1.2. Women’s Digital Health Market for Devices, 2022-2035
13.3.1.3. Women’s Digital Health Market for Services, 2022-2035
13.3.2. Women’s Digital Health Market: Distribution by Therapeutic Application Area, 2022 and 2035
13.3.3. Women’s Digital Health Market: Distribution by Geography, 2022 and 2035
13.3.3.1. Women’s Digital Health Market in North America, 2022-2035
13.3.3.2. Women’s Digital Health Market in Europe, 2022-2035
13.3.3.3. Women’s Digital Health Market in Asia-Pacific, 2022-2035
13.3.3.4. Women’s Digital Health Market in Latin America, 2022-2035
13.3.3.5. Women’s Digital Health Market in Middle East and North Africa, 2022-2035
13.4. Women’s Digital Health Market for Applications / Software, 2022-2035
13.4.1. Women’s Digital Health Market for Applications / Software, 2022-2035: Distribution by Therapeutic Application Area
13.4.1.1. Women’s Digital Health Applications / Software Market for Fetal Health, 2022-2035
13.4.1.2. Women’s Digital Health Applications / Software Market for General Wellness, 2022-2035
13.4.1.3. Women’s Digital Health Applications / Software Market for Menstrual Cycle, 2022-2035
13.4.1.4. Women’s Digital Health Applications / Software Market for Pelvic Care, 2022-2035
13.4.1.5. Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, 2022-2035
13.4.2. Women’s Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography
13.4.2.1. Women’s Digital Health Applications / Software Market in North America, 2022-2035
13.4.2.2. Women’s Digital Health Applications / Software Market in Europe, 2022-2035
13.4.2.3. Women’s Digital Health Applications / Software Market in Asia-Pacific, 2022-2035
13.4.2.4. Women’s Digital Health Applications / Software Market in Latin America, 2022-2035
13.4.2.5. Women’s Digital Health Applications / Software Market in Middle East and North Africa, 2022-2035
13.5. Women’s Digital Health Market for Devices, 2022-2035
13.5.1. Women’s Digital Health Market for Devices, 2022-2035: Distribution by Therapeutic Application Area
13.5.1.1. Women’s Digital Health Device Market for Fetal Health, 2022-2035
13.5.1.2. Women’s Digital Health Device Market for General Wellness, 2022-2035
13.5.1.3. Women’s Digital Health Device Market for Menstrual Cycle, 2022-2035
13.5.1.4. Women’s Digital Health Device Market for Pelvic Care, 2022-2035
13.5.1.5. Women’s Digital Health Device Market for Reproductive Health / Fertility, 2022-2035
13.5.2. Women’s Digital Health Market for Applications / Software, 2022-2035: Distribution by Geography
13.5.2.1. Women’s Digital Health Device Market in North America, 2022-2035
13.5.2.2. Women’s Digital Health Device Market in Europe, 2022-2035
13.5.2.3. Women’s Digital Health Device Market in Asia-Pacific, 2022-2035
13.5.2.4. Women’s Digital Health Device Market in Latin America, 2022-2035
13.5.2.5. Women’s Digital Health Device Market in Middle East and North Africa, 2022-2035
13.6. Women’s Digital Health Market for Services, 2022-2035
13.6.1. Women’s Digital Health Market for Services, 2022-2035: Distribution by Therapeutic Application Area
13.6.1.1. Women’s Digital Health Services Market for Fetal Health, 2022-2035
13.6.1.2. Women’s Digital Health Services Market for General Wellness, 2022-2035
13.6.1.3. Women’s Digital Health Services Market for Menstrual Cycle, 2022-2035
13.6.1.4. Women’s Digital Health Services Market for Pelvic Care, 2022-2035
13.6.1.5. Women’s Digital Health Services Market for Reproductive Health / Fertility, 2022-2035
13.6.1.6. Women’s Digital Health Services Market in North America, 2022-2035
13.6.1.7. Women’s Digital Health Services Market in Europe, 2022-2035
13.6.1.8. Women’s Digital Health Services Market in Asia-Pacific, 2022-2035
13.6.1.9. Women’s Digital Health Services Market in Latin America, 2022-2035
13.6.1.10. Women’s Digital Health Services Market in Middle East and North Africa, 2022-2035

14. ROLE OF DIGITALIZATION IN WOMEN’S LIFE
14.1. Chapter Overview
14.2. Evolution of Digital Solutions for Women during COVID-19 Pandemic
14.2.1. Learning New Skills
14.3. Opportunities in Professional and Personal Life
14.3.1. Small Scale Online Businesses
14.3.2. Demand for Online Financial Products
14.4. Existing Digital Gender Gap
14.4.1. Impact of AI on Digital Gender Gap
14.5. Skills Shortfall
14.6. Strengthening Ways for Digital Adoption among Women

15. DIGITAL TRENDS: RESHAPING THE FUTURE OF HEALTHCARE
15.1. Chapter Overview
15.2. Artificial Intelligence
15.2.1. Role of Artificial Intelligence in Healthcare
15.2.2. Digital Adoption: Companies employing Artificial Intelligence in Healthcare Solutions

15.3. Machine Learning
15.3.1. Role of Machine Learning in Healthcare
15.3.2. Digital Adoption: Companies employing Machine Learning in 

15.4. Deep Learning
15.4.1. Role of Deep Learning in Healthcare

15.5. Metaverse
15.5.1. Role of Metaverse in Healthcare
15.6. Conclusion

16. CONCLUSION 

17. EXECUTIVE INSIGHTS
17.1. Chapter Overview

17.2. iSONO Health
17.2.1. Company Snapshot 
17.2.2. Interview Transcript: Maryam Ziaei, Founder and Chief Executive Officer

17.3. Illumigyn
17.3.1. Company Snapshot 
17.3.2. Interview Transcript: Honny Hillegonda Kipnis Groen, Chief Marketing Officer

17.4. A Thousand Collibris
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Sven Mulfinger (Co-Founder & Chief Operating Officer

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Current Market Landscape
Figure 2.2 Executive Summary: Funding and Investment Analysis
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Global Events Analysis
Figure 2.5 Executive Summary: Product Development and Success Analysis
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Benefits of Digital Health Technologies
Figure 3.2 Women’s Digital Health: Type of Solutions
Figure 3.3 Women’s Digital Health: Challenges
Figure 4.1 Women’s Digital Health: Distribution by Type of Solutions Offered / Available
Figure 4.2 Women’s Digital Health: Distribution by Current Status of Development
Figure 4.3 Women’s Digital Health: Distribution by Ratings of Women’s Digital Health Applications
Figure 4.4 Women’s Digital Health: Distribution by Therapeutic Application Area
Figure 4.5 Women’s Digital Health: Distribution by Usage Period with respect to Pregnancy
Figure 4.6 Women’s Digital Health: Distribution by Purpose
Figure 4.7 Women’s Digital Health: Distribution by End-Users
Figure 4.8 Women’s Digital Health: Distribution by Therapeutic Application Area and Type of Solution
Figure 4.9 Women’s Digital Health Developers: Distribution by Year of Establishment
Figure 4.10 Women’s Digital Health Developers: Distribution by Company Size
Figure 4.11 Women’s Digital Health Developers: Distribution by Region of Headquarters
Figure 4.12 Women’s Digital Health Developers: Distribution by Company Size and Region of Headquarters
Figure 4.13 Women’s Digital Health Developers: Distribution by Location of Headquarters
Figure 4.14 Leading Players: Distribution by Number of Solutions
Figure 5.1 Garmin: Product / Service Portfolio
Figure 5.2 Garmin: Women’s Digital Health Product / Service(s) Offered
Figure 5.3 Kindbody: Product / Service Portfolio
Figure 5.4 Kindbody: Women’s Digital Health Product / Service(s) Offered
Figure 5.5 LetsGetChecked: Product / Service Portfolio
Figure 5.6 LetsGetChecked: Women’s Digital Health Product / Service(s) Offered
Figure 5.7 Maven Clinic: Product / Service Portfolio
Figure 5.8 Maven Clinic: Women’s Digital Health Product / Service(s) Offered
Figure 5.9 Ro: Product / Service Portfolio
Figure 5.10 Ro: Women’s Digital Health Product / Service(s) Offered
Figure 5.11 Willow Innovations: Product / Service Portfolio
Figure 5.12 Willow Innovations: Women’s Digital Health Product / Service(s) Offered
Figure 6.1 Flo Health: Product / Service Portfolio
Figure 6.2 Flo Health: Women’s Digital Health Product / Service(s) Offered
Figure 6.3 Hubble Connected: Product / Service Portfolio
Figure 6.4 Hubble Connected: Women’s Digital Health Product / Service(s) Offered
Figure 6.5 International Medical Center: Product / Service Portfolio
Figure 6.6 International Medical Center: Women’s Digital Health Product / Service(s) Offered
Figure 7.1 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, 2016-2021 (USD Million)
Figure 7.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2016-2021
Figure 7.3 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2016-2021 (USD Million)
Figure 7.4 Funding and Investment Analysis: Distribution by Type of Funding
Figure 7.5 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 7.6 Most Active Players: Distribution by Number of Funding Instances
Figure 7.7 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 7.8 Key Investors: Analysis by Number of Instances
Figure 7.9 Funding and Investments Analysis: Distribution by Type of Solution
Figure 7.10 Funding and Investments: Distribution by Type of Solution and Amount Invested (USD Million)
Figure 7.11 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Application Area (USD Million)
Figure 7.12 Funding and Investment Analysis: Geographical Distribution by Number of Instances and Amount Invested (USD Million)
Figure 7.13 Funding and Investment Analysis: Distribution by Year, Therapeutic Application Area and Amount Invested, 2016-2021 (USD Million)
Figure 7.14 Summary of Investments
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022 (till January)
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022 (till January)
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 8.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2017-2022 (till January)
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Partnership and Product / Solution
Figure 8.7 Most Active Players: Distribution by Number of Partnerships
Figure 8.8 Leading Players: Distribution by Type of Partnership
Figure 8.9 Partnerships and Collaborations: Regional Distribution
Figure 8.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 Start-up Health Indexing: Distribution by Type of Product / Solution
Figure 9.2 Start-up Health Indexing: Distribution by Therapeutic Application Area
Figure 9.3 Start-up Health Indexing: Distribution by Usage Period with respect to Pregnancy
Figure 9.4 Start-up Health Indexing: Distribution by Partnership Activity
Figure 9.5 Start-up Health Indexing: Distribution by Funding Activity
Figure 9.6 Start-up Health Indexing: Distribution by Progression in Funding
Figure 9.7 Start-up Health Indexing: Distribution by Type of Funding
Figure 9.8 Start-up Health Indexing: Distribution by Location of Headquarters
Figure 9.9 Start-up Health Indexing: Roots Analysis Perspective
Figure 10.1 Global Events: Cumulative Half Yearly Trend, H2 2018 - 2022
Figure 10.2 Global Events: Distribution by Event Platform
Figure 10.3 Global Events: Distribution by Type of Event
Figure 10.4 Global Events: Distribution by Location of Event
Figure 10.5 Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Areas
Figure 10.6 Global Events: Historical Trend of Event Agendas, H2 2018 - 2022
Figure 10.7 Most Active Event Organizers: Distribution by Number of Events
Figure 10.8 Most Active Industry Participants: Distribution by Number of Events
Figure 10.9 Global Events: Distribution by Designation of Participant
Figure 10.10 Global Events: Distribution by Affiliated Department of Participant
Figure 10.11 Most Active Speakers: Distribution by Number of Events
Figure 10.12 Global Events: Geographical Mapping of Upcoming Events
Figure 11.1 Women’s Digital Health: SWOT Analysis
Figure 11.2 Comparison of SWOT Factors
Figure 12.1 Product Development and Success Analysis: Key Parameters Impacting Success of Applications and Devices
Figure 12.2 Product Development and Success Analysis: Competitiveness Analysis of Top Applications
Figure 12.3 Product Development and Success Analysis: Average Score Required for the Success of Applications
Figure 12.4 Product Development and Success Analysis: Competitiveness Analysis of Top Devices
Figure 12.5 Product Development and Success Analysis: Average Score Required for the Success of Devices
Figure 12.6 Unmet Needs: Distribution by Therapeutic Application Areas and Type of Solutions
Figure 12.7 Women’s Digital Health Solutions: Estimated Average Number of Users per Solution Across Various Therapeutic Application Areas
Figure 13.1 Overall Women’s Digital Health Market, 2022-2035 (USD Billion)
Figure 13.2 Women’s Digital Health Market: Distribution by Type of Solution, 2022 and 2035
Figure 13.3 Women’s Digital Health Market for Applications / Software, 2022-2035 (USD Billion)
Figure 13.4 Women’s Digital Health Market for Devices, 2022-2035 (USD Billion)
Figure 13.5 Women’s Digital Health Market for Services, 2022-2035 (USD Billion)
Figure 13.6 Women’s Digital Health Market: Distribution by Therapeutic Application Area, 2022 and 2035
Figure 13.7 Women’s Digital Health Market for Menstrual Cycle, 2022-2035 (USD Billion)
Figure 13.8 Women’s Digital Health Market for Reproductive Health / Fertility, 2022-2035 (USD Billion)
Figure 13.9 Women’s Digital Health Market for General Wellness, 2022-2035 (USD Billion)
Figure 13.10 Women’s Digital Health Market for Pelvic Care, 2022-2035 (USD Billion)
Figure 13.11 Women’s Digital Health Market for Fetal Health, 2022-2035 (USD Billion)
Figure 13.12 Women’s Digital Health Market: Distribution by Geography, 2022 and 2035
Figure 13.13 Women’s Digital Health Market in North America, 2022-2035 (USD Billion)
Figure 13.14 Women’s Digital Health Market in Europe, 2022-2035 (USD Billion)
Figure 13.15 Women’s Digital Health Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 13.16 Women’s Digital Health Market in Latin America, 2022-2035 (USD Billion)
Figure 13.17 Women’s Digital Health Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 13.18 Women’s Digital Health Market for Applications / Software: Distribution by Therapeutic Application Area, 2022 and 2035
Figure 13.19 Women’s Digital Health Applications / Software Market for Fetal Health, 2022-2035 (USD Billion)
Figure 13.20 Women’s Digital Health Applications / Software Market for General Wellness, 2022-2035 (USD Billion)
Figure 13.21 Women’s Digital Health Applications / Software Market for Menstrual Cycle, 2022-2035 (USD Billion)
Figure 13.22 Women’s Digital Health Applications / Software Market for Pelvic Care, 2022-2035 (USD Billion)
Figure 13.23 Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, 2022-2035 (USD Billion)
Figure 13.24 Women’s Digital Health Applications / Software Market in North America, 2022-2035 (USD Billion)
Figure 13.25 Women’s Digital Health Applications / Software Market in Europe, 2022-2035 (USD Billion)
Figure 13.26 Women’s Digital Health Applications / Software Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 13.27 Women’s Digital Health Applications / Software Market in Latin America, 2022-2035 (USD Billion)
Figure 13.28 Women’s Digital Health Applications / Software Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 13.29 Women’s Digital Health Market for Devices: Distribution by Therapeutic Application Area, 2022 and 2035
Figure 13.30 Women’s Digital Health Devices Market for Fetal Health, 2022-2035 (USD Billion)
Figure 13.31 Women’s Digital Health Devices Market for General Wellness, 2022-2035 (USD Billion)
Figure 13.32 Women’s Digital Health Devices Market for Menstrual Cycle, 2022-2035 (USD Billion)
Figure 13.33 Women’s Digital Health Devices Market for Pelvic Care, 2022-2035 (USD Billion)
Figure 13.34 Women’s Digital Health Devices Market for Reproductive Health / Fertility, 2022-2035 (USD Billion)
Figure 13.35 Women’s Digital Health Devices Market in North America, 2022-2035 (USD Billion)
Figure 13.36 Women’s Digital Health Devices Market in Europe, 2022-2035 (USD Billion)
Figure 13.37 Women’s Digital Health Devices Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 13.38 Women’s Digital Health Devices Market in Latin America, 2022-2035 (USD Billion)
Figure 13.39 Women’s Digital Health Devices Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 13.40 Women’s Digital Health Market for Services: Distribution by Therapeutic Application Area, 2022 and 2035
Figure 13.41 Women’s Digital Health Services Market for Fetal Health, 2022-2035 (USD Billion)
Figure 13.42 Women’s Digital Health Services Market for General Wellness, 2022-2035 (USD Billion)
Figure 13.43 Women’s Digital Health Services Market for Menstrual Cycle, 2022-2035 (USD Billion)
Figure 13.44 Women’s Digital Health Services Market for Pelvic Care, 2022-2035 (USD Billion)
Figure 13.45 Women’s Digital Health Services Market for Reproductive Health / Fertility, 2022-2035 (USD Billion)
Figure 13.46 Women’s Digital Health Services Market in North America, 2022-2035 (USD Billion)
Figure 13.47 Women’s Digital Health Services Market in Europe, 2022-2035 (USD Billion)
Figure 13.48 Women’s Digital Health Services Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 13.49 Women’s Digital Health Services Market in Latin America, 2022-2035 (USD Billion)
Figure 13.50 Women’s Digital Health Services Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 14.1 Evolution of Digital Concept Among Women: Role of Digitalization in Women’s Life during COVID-19 Pandemic
Figure 14.2 Evolution of Digital Concept Among Women: Demand for Online Financial Products
Figure 14.3 Evolution of Digital Concept Among Women: Unequal Opportunities in Jobs
Figure 14.4 Evolution of Digital Concept Among Women: Skills Shortfall
Figure 14.5 Evolution of Digital Concept Among Women: Strengthening Ways for the Digital Inclusion among Women
Figure 15.1 Digital Adoption: Applications of Artificial Intelligence in Healthcare
Figure 15.2 Digital Adoption: Applications of Machine Learning in Healthcare
Figure 15.3 Digital Adoption: Applications of Deep Learning in Healthcare
Figure 15.4 Digital Adoption: Applications of Metaverse in Healthcare

List Of Tables

Table 4.1 Women’s Digital Health: Information on Type of Solution and Therapeutic Application Area
Table 4.2 Women’s Digital Health: Information on Current Status of Development and Ratings of Women’s Digital Health Applications
Table 4.3 Women’s Digital Health: Information on Usage in Pregnancy, Purpose and End-Users
Table 4.4 Women’s Digital Health: Developer Landscape
Table 5.1 Women’s Digital Health Market in North America: List of Companies Profiled
Table 5.2 Garmin: Company Snapshot
Table 5.3 Kindbody: Company Snapshot
Table 5.4 Kindbody: Recent Developments and Future Outlook
Table 5.5 LetsGetChecked: Company Snapshot
Table 5.6 LetsGetChecked: Recent Developments and Future Outlook
Table 5.7 Maven Clinic: Company Snapshot
Table 5.8 Maven Clinic: Recent Developments and Future Outlook
Table 5.9 Ro: Company Snapshot
Table 5.10 Ro: Recent Developments and Future Outlook
Table 5.11 Willow Innovations: Company Snapshot
Table 6.1 Women’s Digital Health Market in Europe, Asia-Pacific and Middle East & North Africa: List of Companies Profiled
Table 6.2 Flo Health: Company Snapshot
Table 6.3 Flo Health: Recent Developments and Future Outlook
Table 6.4 Hubble Connected: Company Snapshot
Table 6.5 International Medical Center: Company Snapshot
Table 7.1 List of Funding Instances, 2016-2021: Information on Company, Year of Funding, Type, Amount Invested and Investors
Table 7.2 List of Funding Instances, 2016-2021: Information on Solutions and Therapeutic Application Area
Table 8.1 Women’s Digital Health: List of Partnerships and Collaborations, 2017-2022 (till January)
Table 10.1 List of Global Events related to Women’s Digital Health
Table 12.1 List of Applications Developed for Women’s Digital Health
Table 12.2 Flo: Product Development and Success Analysis Parameters
Table 12.3 Clue Period Tracker: Product Development and Success Analysis Parameters
Table 12.4 Ovulation & Period Tracker: Product Development and Success Analysis Parameters
Table 12.5 NC° Birth Control: Product Development and Success Analysis Parameters
Table 12.6 Maya: Product Development and Success Analysis Parameters
Table 12.7 List of Marketed Devices Developed for Women’s Digital Health
Table 12.8 Elvie Trainer: Product Development and Success Analysis Parameters
Table 12.9 Ivy: Product Development and Success Analysis Parameters
Table 12.10 breathe ilo: Product Development and Success Analysis Parameters
Table 12.11 Roo: Product Development and Success Analysis Parameters
Table 12.12 Embr Wave 2: Thermal Wellness: Product Development and Success Analysis Parameters
Table 12.13 Unmet Needs: Distribution by Therapeutic Application Areas and Type of Solutions
Table 12.14 Unmet Needs: Type of Solutions and Usage Period of Solution with respect to Pregnancy
Table 13.1 Women’s Digital Health: List of Applications / Software
Table 13.2 Women’s Digital Health: List of Devices
Table 15.1 Digital Adoption: Companies employing Artificial Intelligence in Healthcare
Table 15.2 Digital Adoption: Companies employing Machine Learning in Healthcare
Table 17.1 iSONO Health: Company Snapshot
Table 17.2 Illumigyn: Company Snapshot
Table 17.3 A Thousand Collibris: Company Snapshot
Table 18.1 Women’s Digital Health: Distribution by Type of Solution Offered / Available
Table 18.2 Women’s Digital Health: Distribution by Current Status of Development
Table 18.3 Women’s Digital Health: Distribution by Ratings of Women’s Digital Health Applications
Table 18.4 Women’s Digital Health: Distribution by Therapeutic Application Area
Table 18.5 Women’s Digital Health: Distribution by Usage Period with respect to Pregnancy
Table 18.6 Women’s Digital Health: Distribution by Purpose
Table 18.7 Women’s Digital Health: Distribution by End-Users
Table 18.8 Women’s Digital Health: Distribution by Application Area and Type of Solution
Table 18.9 Women’s Digital Health Developers: Distribution by Year of Establishment
Table 18.10 Women’s Digital Health Developers: Distribution by Company Size
Table 18.11 Women’s Digital Health Developers: Distribution by Region of Headquarters
Table 18.12 Women’s Digital Health Developers: Distribution by Company Size and Region of Headquarters
Table 18.13 Women’s Digital Health Developers: Distribution by Location of Headquarters
Table 18.14 Leading Players: Distribution by Number of Solutions
Table 18.15 Funding and Investment Analysis: Distribution by Year, Type of Funding and Amount Invested, 2016-2021 (USD Million)
Table 18.16 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2016-2021
Table 18.17 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2016-2021 (USD Million)
Table 18.18 Funding and Investment Analysis: Distribution by Type of Funding
Table 18.19 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 18.20 Most Active Players: Distribution by Number of Funding Instances
Table 18.21 Most Active Players: Distribution by Amount Raised (USD Million)
Table 18.22 Key Investors: Distribution by Number of Instances
Table 18.23 Popular Solutions: Distribution by Number of Instances
Table 18.24 Popular Solutions: Distribution by Amount Invested (USD Million)
Table 18.25 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Application Area (USD Million)
Table 18.26 Funding and Investment Analysis: Geographical Distribution by Number of Instances and Amount Invested (USD Million)
Table 18.27 Funding and Investment Analysis: Distribution by Year, Therapeutic Application Area and Amount Invested, 2016-2021 (USD Million)
Table 18.28 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022 (till January)
Table 18.29 Partnerships and Collaborations: Distribution by Type of Partnership
Table 18.30 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022 (till January)
Table 18.31 Partnerships and Collaborations: Distribution by Type of Partner
Table 18.32 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2017-2022 (till January)
Table 18.33 Partnerships and Collaborations: Distribution by Type of Partnership and Product / Solution
Table 18.34 Most Active Players: Distribution by Number of Partnerships
Table 18.35 Leading Players: Distribution by Type of Partnership
Table 18.36 Partnerships and Collaborations: Regional Distribution
Table 18.37 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 18.38 Global Events: Cumulative Half Yearly Trend, H2 2018 - 2022
Table 18.39 Global Events: Distribution by Event Platform
Table 18.40 Global Events: Distribution by Type of Event
Table 18.41 Global Events: Distribution by Location of Event
Table 18.42 Most Active Event Organizers: Distribution by Number of Events
Table 18.43 Most Active Industry Participants: Distribution by Number of Events
Table 18.44 Global Events: Distribution by Designation of Participant
Table 18.45 Global Events: Distribution by Affiliated Department of Participant
Table 18.46 Most Active Speakers: Distribution by Number of Events
Table 18.47 Overall Women’s Digital Health Market, 2022-2035 (USD Billion)
Table 18.48 Women’s Digital Health Market: Distribution by Type of Solution, 2022 and 2035
Table 18.49 Women’s Digital Health Market for Applications / Software, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.50 Women’s Digital Health Market for Devices, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.51 Women’s Digital Health Market for Services Offered / Available, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.52 Women’s Digital Health Market: Distribution by Therapeutic Application Area, 2022 and 2035
Table 18.53 Women’s Digital Health Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.54 Women’s Digital Health Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.55 Women’s Digital Health Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.56 Women’s Digital Health Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.57 Women’s Digital Health Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.58 Women’s Digital Health Market: Distribution by Geography, 2022 and 2035
Table 18.59 Women’s Digital Health Market in North America, 2022-2035 (USD Billion)
Table 18.60 Women’s Digital Health Market in Europe, 2022-2035 (USD Billion)
Table 18.61 Women’s Digital Health Market in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.62 Women’s Digital Health Market in Latin America, 2022-2035 (USD Billion)
Table 18.63 Women’s Digital Health Market in Middle East and North Africa, 2022-2035 (USD Billion)
Table 18.64 Women’s Digital Health Market for Applications / Software: Distribution by Therapeutic Application Area, 2022 and 2035
Table 18.65 Women’s Digital Health Applications / Software Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.66 Women’s Digital Health Applications / Software Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.67 Women’s Digital Health Applications / Software Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.68 Women’s Digital Health Applications / Software Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.69 Women’s Digital Health Applications / Software Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.70 Women’s Digital Health Applications / Software Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.71 Women’s Digital Health Applications / Software Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.72 Women’s Digital Health Applications / Software Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.73 Women’s Digital Health Applications / Software Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.74 Women’s Digital Health Applications / Software Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.75 Women’s Digital Health Market for Devices: Distribution by Therapeutic Application Area, 2022 and 2035
Table 18.76 Women’s Digital Health Device Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.77 Women’s Digital Health Device Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.78 Women’s Digital Health Device Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.79 Women’s Digital Health Device Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.80 Women’s Digital Health Device Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.81 Women’s Digital Health Device Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.82 Women’s Digital Health Device Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.83 Women’s Digital Health Device Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.84 Women’s Digital Health Device Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.85 Women’s Digital Health Device Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.86 Women’s Digital Health Market for Service: Distribution by Therapeutic Application Area, 2022 and 2035
Table 18.87 Women’s Digital Health Service Market for Fetal Health, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.88 Women’s Digital Health Service Market for General Wellness, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.89 Women’s Digital Health Service Market for Menstrual Cycle, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.90 Women’s Digital Health Service Market for Pelvic Care, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.91 Women’s Digital Health Service Market for Reproductive Health / Fertility, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.92 Women’s Digital Health Service Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.93 Women’s Digital Health Service Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.94 Women’s Digital Health Service Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.95 Women’s Digital Health Service Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 18.96 Women’s Digital Health Service Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. 2048 Ventures
  2. 4FO Ventures
  3. 8VC
  4. a thousand colibris  
  5. Aavia
  6. Advanced Maternity Innovations
  7. AH Trust
  8. Aindra Systems
  9. Alife Health
  10. Allara Health
  11. Alpha Femtech
  12. Alsace Business Angels
  13. AltaIR Capital
  14. Althea Group 
  15. Altitude Ventures
  16. Alumni Ventures
  17. Amadeus Capital Partners
  18. Amboy Street Ventures
  19. Anastasia Kovba
  20. Anchorless Bangladesh
  21. Andera Partners
  22. AngelList Venture
  23. Anthem
  24. AOA
  25. Astute
  26. Autonomous Open Innovation (AOI)
  27. App Basic
  28. Apricity
  29. Arbor Health
  30. ArlanWasHere Investments
  31. Artesian
  32. Ascension Ventures
  33. ASPIVIX
  34. Asset Management Ventures
  35. Astinno
  36. Athena
  37. Atheneum 
  38. Atlantic Therapeutics
  39. AtlasV Global
  40. Atomico
  41. Ava 
  42. Avaana Capital
  43. Avestria Ventures
  44. Awesome People Ventures
  45. AXA
  46. Baby2Body
  47. Babyscripts
  48. Backstage Capital
  49. Balance
  50. Balderton Capital
  51. BBG Ventures
  52. Beehive Holdings
  53. Bellabeat
  54. Bethnal Green Ventures
  55. BGF
  56. Bia Med
  57. Blackbird Ventures
  58. Bloomer Tech
  59. Bloomlife
  60. Bloomth
  61. Blossom Capital
  62. Blue Cross Blue Shield of Massachusetts
  63. Blue Ox Healthcare Partners
  64. BlueRun Ventures 
  65. Bolt Ventures
  66. Bonnier Ventures
  67. Bonzun
  68. Borski Fund
  69. Braster
  70. BrightCap Ventures
  71. Brilliantly
  72. btov Partners
  73. B-wom
  74. Cambridge Design Partnership
  75. Cambridge Digital Health
  76. Cambridge Femtech Society
  77. Candlelit
  78. Canopie
  79. Capier Investments
  80. Carbomed Medical Solutions
  81. Care4Cute
  82. CareSignal
  83. Carrot
  84. Casdin Capital
  85. Cayaba Care
  86. Charles River Ventures
  87. Chiaroscuro Foundation
  88. Chorus Health
  89. Cigna Ventures
  90. Claritas Health Ventures
  91. Clementine
  92. Clue
  93. Collaborative Fund
  94. Company Ventures
  95. Conference Series
  96. Connors Centre 
  97. Coroflo
  98.    Cortado Ventures
  99.    Council For Trade and Investment Promotion (CTIP)
  100. COYA Partners
  101. Creative Destruction Lab
  102. Crescent Ridge Partners
  103. Development Bank of Wales
  104. Digital Health Today
  105. DigiTx Partners
  106. Downing Ventures
  107. Dragoneer Investment Group
  108. Dream Incubator
  109. drip. menstrual cycle and fertility tracking
  110. Ease Healthcare
  111. Efficient Capacity
  112. EIT Health
  113. ElaWoman
  114. Elda Health
  115. Eli Health
  116. Elidah
  117. EloCare
  118. Elvie
  119. Elysium Venture Capital
  120. Embr
  121. Emme
  122. Endeavour Vision
  123. Endodiag
  124. Endometrix
  125. Enterprise Ireland
  126. Enzia Ventures
  127. EQT Ventures
  128. eQventure
  129. European Commission
  130. European Innovation Council and SMEs Executive Agency (EISMEA)
  131. Evernow
  132. Exandus
  133. Faegre Drinker
  134. Fairhaven Health
  135. Femasys
  136. Femcare - Reverse PCOS, Consult Doctor Online
  137. Femcy
  138. FEMM
  139. FEMNA
  140. Femometer
  141. FemTech Analytics
  142. Femtech Focus
  143. FemTec Healthcare
  144. FemX
  145. Ferne
  146. Fertility Focus
  147. FetoLife
  148. First Round Capital
  149. FirstCheck Africa
  150. FirstMark Capital
  151. Fish & Richardson
  152. Fizimed
  153. Flare Capital Partners
  154. Flint Capital
  155. Flo Health
  156. Flöka
  157. Fondation pour l'Innovation Technologique (FIT)
  158. Forerunner Ventures
  159. Foresight Group
  160. Fortunis Capital
  161. Founder Institute
  162. Founders Fund
  163. Foview
  164. Frame Fertility
  165. Frost & Sullivan
  166. Frøya
  167. Fuel Ventures
  168. Future Positive Capital
  169. Gals Bio
  170. Garmin
  171. gBETA Medtech
  172. Gedeon Richter
  173. General Catalyst 
  174. Gennev
  175. Global Founders Capital
  176. Glow
  177. Google
  178. Grand Central Tech
  179. Greycroft
  180. GSK NEXT
  181. GV
  182. Hackster
  183. Halza
  184. Hambrecht Ducera Growth Ventures
  185. Harvard Business School Association of Northern California (HBSANC)
  186. Harvard Medical School
  187. Harvard University
  188. HAX
  189. Haxus
  190. Health & Her
  191. Health Enterprise Partners (HEP)
  192. Health in Her HUE
  193. HealthXL
  194. HeraMED
  195. Hikma Ventures
  196. HITLAB
  197. Hiventures
  198. HLM Venture Partners
  199. Horizon 2020
  200. Hubble Connected
  201. Hybrid4apps
  202. iBreve
  203. Icon Ventures
  204. Illumigyn
  205. Illumina Ventures
  206. iMama
  207. Impact Ventures UK
  208. Information Technology Academia Collaboration (ITAC)
  209. Inito
  210. Inne
  211. Innovate UK
  212. Inova Health System
  213. Insignia Ventures Partners
  214. International Medical Center Apps
  215. IPOPEMA Securities
  216. iSono Health
  217. Iterative Capital 
  218. iXensor
  219. January Ventures
  220. Jennis
  221. Johnson Venture Partners (JVP)
  222. Kamet Ventures
  223. kegg
  224. Kheiron Medical Technologies
  225. Khyria
  226. Kindbody
  227. Konna
  228. Kormeli
  229. LabQ International
  230. Lactamo
  231. LactApp
  232. Lactation Lab
  233. LAIA
  234. Leap Fitness Group
  235. Leerink Transformation Partners
  236. Lemonaid Health
  237. LetsGetChecked
  238. Life Science Innovation Fund
  239. LifeSense Group (LSG)
  240. Linchpin Healthcare
  241. Lisa Health
  242. Livia
  243. League of Innovators
  244. LSP
  245. Lucina Analytics
  246. Luma Womb
  247. Lux Capital
  248. Mabel
  249. Mae
  250. Magnetic Ventures
  251. Mahmee
  252. Maki.vc
  253. Mangrove Capital Partners
  254. MassChallenge
  255. Material Impact
  256. Materna Medical
  257. Maven Clinic
  258. Maven Ventures
  259. Maveron
  260. Maya 
  261. McKinsey
  262. MEDITA
  263. Medtech Women
  264. MemorialCare Innovation Fund (MCIF)
  265. Menopod
  266. Merchavia
  267. Meridian Street Capital
  268. Meritech Capital Partners
  269. Meta
  270. Metronomic 
  271. Microsoft
  272. Midlands Engine Investment Fund (MEIF)
  273. MiMARK
  274. Miracare
  275. Mirco Bettelini
  276. Massachusetts Institute of Technology (MIT)
  277. MMD
  278. MobileODT
  279. Modern Fertility 
  280. Monkfish Equity
  281. MooDoos Investments
  282. Moonai
  283. Modern Fertility
  284. MUTU
  285. My Ava
  286. Nabta Health
  287. National Cancer Institute (NCI)
  288. National Education Association (NEA)
  289. National Health Service (NHS)
  290. National Institutes of Health (NIH)
  291. National Science Foundation (NSF)
  292. Natural Cycles
  293. Naytal
  294. Nest Collaborative
  295. New England-Israel Business Council (NEIBC)
  296. Nex Cubed
  297. Nexus Venture Partners
  298. NGP Capital
  299. Niramai
  300. Nordic Eye Venture Capital
  301. Novartis Venture Fund
  302. NursElet
  303. Nuvo Group
  304. Oak HC/FT 
  305. Oath Care
  306. OCON Healthcare
  307. Octopus Ventures
  308. Oky
  309. Olive Tree Ventures
  310. Oova
  311. Optum Ventures
  312. Oratel Diagnostics
  313. OrbiMed Advisors
  314. Ordinary Folk
  315. Orreco
  316. OSF Ventures
  317. Oshihar Apps
  318. Oula
  319. Ovia Health
  320. Ovira
  321. Ovulai
  322. Ovulation Calculator
  323. Pachamama
  324. Parentlane
  325. Parian Global Management
  326. Partum Health
  327. Pepapp
  328. Peramare Enterprises
  329. Perceptive Advisors
  330. PeriGen
  331. Phenomenal Women's Health
  332. pi Ventures
  333. Plackal Tech 
  334. Plug and Play Tech Centre
  335. Polytech Ventures
  336. Pomelo Care
  337. Pontifax Venture Capital
  338. PreemieWorld
  339. PregnaScan
  340. Prima-Temp
  341. Prime Venture Partners
  342. Privia Health
  343. Proactive for her
  344. Proov
  345. Public Policy Projects (PPP)
  346. pumpspotting
  347. Punchbowl
  348. Qiming Venture Partners
  349. Qualcomm Life
  350. Raiing Medical
  351. Raydiant Oximetry
  352. Renalis
  353. Renovia
  354. Rhia Ventures
  355. Ro
  356. Roche 
  357. Royal Philips
  358. RRE Ventures
  359. Sagentia Innovation
  360. Salem Partners
  361. Santora Nakama
  362. Scientific Federation
  363. SD Venture
  364. Seashore Solutions
  365. Sequoia Capital
  366. Sera Prognostics
  367. Serena Ventures
  368. Seroba Life Sciences
  369. Sevenlogics
  370. Shareholder Value Management
  371. She Loves Tech
  372. SOSV
  373. Spring Mountain Capital
  374. Springboard Enterprises
  375. Srirakshaa Healthcare
  376. Starting Line
  377. StartUp Health
  378. State of Maine
  379. SteadySense
  380. SteelSky Ventures
  381. Storka
  382. Summit Reinsurance Services
  383. SVC
  384. Swiss Healthcare Startups (SHS)
  385. Syrona Health
  386. Tamtris Web Services
  387. Target Global
  388. Tech Up For Women
  389. Tech4Eva
  390. Techammer
  391. Techstars
  392. Tempdrop
  393. Texas HALO Fund
  394. The Body Literacy Collective
  395. The Female Health Hub
  396. International Technology Law Association (ITechLaw)
  397. The Lily Project
  398. The Pelvic Expert
  399. Royal Society
  400. Royal Society of Medicine 
  401. Yozma
  402. Think Bigger Capital
  403. Tia
  404. Tiger Global Management
  405. Titan Capital  
  406. Tooly Tech
  407. TruDiary
  408. True Ventures
  409. Tutorify
  410. U.S. Venture Partners
  411. Ubicom Holdings
  412. Uncork Capital
  413. Union Square Ventures
  414. United Nations University International Institute for Global Health (UNU-IIGH)
  415. UnityPoint Health Ventures
  416. University Hospitals
  417. Uvi Health
  418. VCapital 
  419. Vectr Ventures
  420. Veera Health 
  421. Velmio
  422. Venture Kick
  423. Victorum Capital Club
  424. Vivant
  425. VNV Global
  426. Vulvy
  427. Wachanga
  428. Walking Ventures
  429. Watkins-Conti Products
  430. Wavemaker 360
  431. Western Development Commission
  432. Wildflower Health
  433. Willow
  434. Women in Technology International WITI
  435. Women In Bio
  436. Women in Data
  437. Women of Wearables (WoW)
  438. Women's Health Connecticut  
  439. WomenUP
  440. Woom
  441. Xpectives.Health
  442. Y Combinator
  443. Yesmom
  444. Ysios Capital
  445. Zaya
  446. Zero Mothers Die
  447. Zoie Health

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.